Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
26.50%
Grew
—
—
Shrank
—
1 Year
Score—
Net Growth26.50%
Net TrendGrew
Net Income Consistency—
Rev Growth—
Rev TrendShrank
Revenue Consistency—
5 Years
—
10.08%
60%
—
—
Never
—
5 Years
Score—
Net Growth10.08%
Net Trend60%
Net Income Consistency—
Rev Growth—
Rev TrendNever
Revenue Consistency—
Anavex Life Sciences Corp fundamental performance
Across Anavex Life Sciences Corp's full reported history, from 2006 to 2025, net income went from -$ 25.53K to -$ 46M. Revenue increased in 8% of the years measured; net income in 35%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 3.41 | — |
1 Year2025-08-12 | $ 10.78 | -68.37% |
5 Years2021-08-12 | $ 19.27 | -82.30% |
10 Years2016-08-12 | $ 3.70 | -7.84% |
20 Years2006-08-11 | $ 8.24 | -58.62% |
All Time2006-08-02 | $ 8.00 | -57.38% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | 20 Years2006-08-11 | All Time2006-08-02 |
|---|---|---|---|---|---|---|
| Price | $ 3.41 | $ 10.78 | $ 19.27 | $ 3.70 | $ 8.24 | $ 8.00 |
| Return | — | -68.37% | -82.30% | -7.84% | -58.62% | -57.38% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 0.00 | -$ 34M | $ 127M |
| 2025 | $ 0.00 | -$ 46M | $ 102M |
| 2024 | $ 0.00 | -$ 43M | $ 132M |
| 2023 | $ 0.00 | -$ 47M | $ 151M |
| 2022 | $ 0.00 | -$ 47M | $ 149M |
| 2021 | $ 0.00 | -$ 37M | $ 152M |
| 2020 | $ 0.00 | -$ 26M | $ 29M |
| 2019 | -$ 685K | -$ 26M | $ 22M |
| 2018 | $ 0.00 | -$ 17M | $ 22M |
| 2017 | $ 0.00 | -$ 13M | $ 27M |
| 2016 | $ 0.00 | -$ 14M | $ 9M |
| 2015 | $ 0.00 | -$ 12M | $ 15M |
| 2014 | $ 0.00 | -$ 11M | $ 7M |
| 2013 | $ 0.00 | -$ 3M | $ 345.07K |
| 2012 | -$ 8M | $ 11.36K | |
| 2011 | -$ 7M | $ 134.7K | |
| 2010 | -$ 8M | $ 264.67K | |
| 2009 | -$ 5M | $ 350.99K | |
| 2008 | -$ 5M | $ 6.36K | |
| 2007 | -$ 1M | $ 25.00 | |
| IPO2006 | -$ 25.53K | $ 12.28K |
Explore beyond AVXL
You're looking at Anavex Life Sciences Corp. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
